Resultados de la búsqueda 31-40 of 12603 for Necrotising soft-tissue infection

  1. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine whether adding clofazimine in a treatment regimen for patients with non-tuberculous mycobacterial (NTM) infections ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    Variables evaluated will include postoperative complications including death within 30 days, wound infection, length of hospital stay, and readmission rates.

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... soft-tissue sarcoma patients. In the study, 122 patients will be randomized in a 1:1 ratio to receive doxorubicin treatment (Arm 1) or L19TNF treatment in ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... soft-tissue sarcoma patients. In the study, 122 patients will be randomized in a 1:1 ratio to receive doxorubicin treatment (Arm 1) or L19TNF treatment in ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... soft-tissue sarcoma patients. In the study, 122 patients will be randomized in a 1:1 ratio to receive doxorubicin treatment (Arm 1) or L19TNF treatment in ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... soft-tissue sarcoma patients. In the study, 122 patients will be randomized in a 1:1 ratio to receive doxorubicin treatment (Arm 1) or L19TNF treatment in ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...